[An interpretation of European guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease].
Nonalcoholic fatty liver disease (NAFLD) is a pathological manifestation of obesity and metabolic syndrome involving the liver. It can cause disability and mortality related to liver disease, and it is closely associated with the high incidence rates of type 2 diabetes and cardiovascular diseases. At present, NAFLD has become the most common chronic liver disease worldwide, and the development and implementation of the clinical guideline for the diagnosis and treatment of NAFLD help to improve patients' prognosis. This article provides an interpretation of the latest Europeans guidelines through a comparative analysis of the previous and latest Europeans guidelines.